Home » Topics » Regulatory » Patents

Patents
RSS

FPTase inhibitors in early development at Merck & Co.

Jan. 27, 1997

Excitatory amino acid receptor ligands from Schering AG

Jan. 27, 1997

Improved fibrinogen antagonists from DuPont Merck

Jan. 27, 1997

Fujisawa investigates tachykinin antagonists

Jan. 24, 1997

MMP inhibitors disclosed by Fuji Yakuhin

Jan. 24, 1997

Roche presents new antifungal agents

Jan. 24, 1997

Novel cytotoxic protein derived from bacterial source

Jan. 24, 1997

Antifungal echinocandin derivatives reported by Lilly

Jan. 24, 1997

New antiasthma agents reported by Sandoz

Jan. 24, 1997

New alpha1-adrenoceptor antagonists from Roche

Jan. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.